Table 1 Baseline characteristics of patients with elevated office blood pressure at two consecutive visits
Parameter | |
|---|---|
n | 212 |
Age (years, range) | 53.2±13.5 (25–82) |
Sex (female/male, n) | 42.5% (90)/57.5% (122) |
Body mass index (kg m–2) | 27.1±4.9 |
Office blood pressure (mm Hg) | |
Visit 1 (SBP/DBP) | 162±6/100±6 |
Visit 2 (SBP/DBP) | 153±14/96±9 |
Blood pressure stage (1/2/3) | 17.5/65/17.5% |
Ambulatory blood pressure (mm Hg) | |
24 h (SBP/DBP) | 134±12/83±9 |
Day (SBP/DBP) | 139±12/87±9 |
Night (SBP/DBP) | 126±14/76±9 |
White coat hypertension | 23.1% |
Risk factors | |
Smoking | 38.2% |
Dyslipidemia | 23.6% |
Obesity | 21.7% |
Physical inactivity | 48.6% |
Family history of CV disease | 40.1% |
Risk factor count (0/1–2/⩾3) | 5.7/61.3/33.0% |
Target organ damage | |
Echo parameters | |
Left ventricular mass (g) | 207±59 |
Cardiac mass index (g m–2) | 111±28 |
Echocardiographic LVH | 28.3% |
E/A ratio | 1.08±0.3 |
ECG parameters | |
Sokolow-Lyon index (>3.5 mV) | 9.4% |
Cornell product (>2440 mV × ms) | 16.5% |
Electrocardiographic LVH | 21.2% |
Microalbuminuria | 19.3% |
Hypertensive retinopathy III/IV | 3.9% |
Associated clinical conditions | |
Diabetes mellitus | 5.6% |
Evidence of CV or renal disease | 7.1% |
